Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001415889-24-006702 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-05 | 2024-03-01 | KNSA | Tessari Eben | COO | S - Sale+OE | $22.03 | -1,189 | 122.8K | -1.0% | -$26.2K |
| D | 2024-03-05 | 2024-03-01 | KNSA | Tessari Eben | COO | M - OptEx | $1.59 | +656 | 124.0K | +0.5% | +$1,043 |
| D | 2024-03-05 | 2024-03-01 | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | -656 | 56.0K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2024-03-01 | S | D | 1,189 | $22.03 | 122,847 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $22.03 and $22.055. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 2 | Common | Class A Common Share | 2024-03-01 | M | A | 656 | $1.59 | 124,036 | D | — | — | |
| 3 | Derivative | Share Option | 2024-03-01 | M | D | 656 | $0.00 | 56,017 | D | $1.59 · — to 2025-12-15 | 656 Class A Common Share | (F3) The option is fully vested and exercisable. |